awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28728904-E4C01920-101E-431E-92F5-99C6AD940E76
Q28728904-E4C01920-101E-431E-92F5-99C6AD940E76
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28728904-E4C01920-101E-431E-92F5-99C6AD940E76
Exploiting modern cannabinoid pharmacology for therapeutic gain?
P2860
Q28728904-E4C01920-101E-431E-92F5-99C6AD940E76
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28728904-E4C01920-101E-431E-92F5-99C6AD940E76
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64a92d2f34126679fa43c4fd93e0c2481142c2af
P2860
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.